Alfuzosin Hydrochloride
- Product NDC
- 71335-1529
- 11-digit product format
- 713351529
- Labeler code
- 71335
- Product ID
- 71335-1529_13c0f39e-2b56-4db7-b86c-aa38bd765508
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA079057
- Marketing category
- ANDA
- Marketing start
- 2011-11-22
- Marketing end
- 0000-00-00
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1529-1 | 71335152901 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1529-1) | 2020-03-05 | 0000-00-00 | No | No | Current |
| 71335-1529-2 | 71335152902 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1529-2) | 2021-12-28 | 0000-00-00 | No | No | Current |
| 71335-1529-3 | 71335152903 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1529-3) | 2021-12-28 | 0000-00-00 | No | No | Current |
| 71335-1529-4 | 71335152904 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1529-4) | 2021-12-28 | 0000-00-00 | No | No | Current |